J. Barrett

Xingmin Feng, N. Young, J. Maciejewski, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non‐myeloablative stem cell transplants

R. Childs, J. Barrett, 2000, British journal of haematology.

The Graft-Versus-Tumor Effect

J. Barrett, Yin-Zhen Jiang, 2000 .

Non-myeloablative stem cell transplants. Annotation

R. Childs, J. Barrett, 2000 .

Opportunities and limitations of NK cells as adoptive therapy for malignant disease

K. Rezvani, J. Barrett, James O. J. Davies, 2014 .

before and after stem cell transplantation in healthy individuals and in patients with chronic myelogenous leukemia T cells exist + Functional leukemia-associated antigen-specific memory CD8

D. Douek, J. Brenchley, K. Rezvani, 2009 .

M. Bar, G. Mufti, S. Grupp, 2021 .

Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

Y. Saunthararajah, J. Barrett, J. Molldrem, 2000, Seminars in hematology.

Allogeneic stem cell transplantation for chronic myeloid leukemia.

J. Barrett, 2003, Seminars in hematology.

Molecular remission of chronic myeloid leukaemia following a non‐myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft‐versus‐leukaemia effect

R. Childs, J. Barrett, E. Clave, 1999, British journal of haematology.

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

N. Hensel, J. Tisdale, R. Childs, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The allogeneic CD4+ T-cell-mediated graft-versus-leukemia effect.

J. Barrett, Y. Z. Jiang, 1997, Leukemia & lymphoma.

A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)‐Fc fusion protein in patients with myelodysplastic syndrome

N. Geller, N. Young, J. Maciejewski, 2002, British journal of haematology.

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.

J. Goldman, A. Chase, N. Cross, 1994, Blood.

Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma

F. Zhan, B. Barlogie, J. Shaughnessy, 2007, Journal of immunotherapy.

ALLOGENEIC IMMUNOTHERAPY : THE GRAFT-VERSUS-LEUKEMIA

R. Childs, J. Barrett, 2005 .

Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features

N. Young, M. Stetler-Stevenson, Y. Saunthararajah, 2001, British journal of haematology.

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

D. Follmann, N. Young, Y. Saunthararajah, 2001, Blood.

Myelodysplastic syndrome and aplastic anemia--diagnostic and conceptual uncertainties.

J. Barrett, 2000, Leukemia research.

GVL Effects in Human Marrow Stem-Cell Transplants

J. Barrett, Yin-Zhen Jiang, 2000 .

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

L. Pagano, M. Perales, I. Yakoub-Agha, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The graft-versus-leukemia effect.

J. Barrett, V. Malkovska, Dimitrios Mavroudis, 1996, Current opinion in oncology.

Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience.

P. Hanley, C. Bollard, J. Galipeau, 2017, Cytotherapy.

Allogeneic stem cell transplantation as immunotherapy for nonhematological cancers.

R. Srinivasan, R. Childs, J. Barrett, 2004, Seminars in oncology.

The benefits of an alloresponse: graft-versus-tumor.

R. Childs, J. Barrett, 2000, Journal of hematotherapy & stem cell research.

Allogeneic Immunotherapy for Malignant Diseases

J. Barrett, Y. Z. Jiang, 2000 .

Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study

Marcus Y. Chen, J. Barrett, M. Battiwalla, 2018, Bone Marrow Transplantation.

Immunosuppressive Treatment Is Associated with Durable Responses and a Survival Advantage in Younger Patients with int-1 Myelodysplastic Syndrome.

P. Greenberg, N. Young, E. Sloand, 2005 .

Nephrotic syndrome: an under‐recognised immune‐mediated complication of non‐myeloablative allogeneic haematopoietic cell transplantation

N. Geller, R. Srinivasan, Y. Takahashi, 2005, British journal of haematology.

The Clinical and Financial Burden of Preemptive Management of CMV Disease after Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches

P. Muranski, R. Childs, J. Barrett, 2014 .

T Cell Exhaustion and Downregulation of Cytotoxic NK Cells – an Immune Escape Mechanism in Adult Acute Lymphoblastic Leukemia

P. Muranski, K. Keyvanfar, C. Hourigan, 2014 .

Point-counterpoint: haploidentical family donors versus cord blood transplantation.

R. Handgretinger, E. Gluckman, J. Barrett, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation using non-myeloablative transplant regimens.

J. Barrett, M. Battiwalla, John Barrett, 2001, Best practice & research. Clinical haematology.

Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor

R. Childs, J. Barrett, S. Leitman, 2015, Journal of Hematology & Oncology.

The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia

D. Arber, J. Cortes, M. Tallman, 2020, Journal for ImmunoTherapy of Cancer.

Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature

G. Fahle, A. Zelazny, J. Barrett, 2017, Open forum infectious diseases.

Successful treatment of periodontal mucormycosis: report of a case and literature review.

M. Merino, P. Waterman, T. Walsh, 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii

D. Wareham, F. Kloprogge, J. Standing, 2019, The Journal of antimicrobial chemotherapy.

Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem cell transplantation for myelodysplastic syndrome – response to Nakamura et al

T. Igarashi, R. Childs, J. Barrett, 2007 .

The Role of the Immune System in Anti-Tumour Responses

C. Gambacorti-Passerini, J. Barrett, S. Dermime, 1995 .

Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells

Xingmin Feng, S. Kajigaya, Shouguo Gao, 2022, Nature Communications.

Genetic trickery--escape of leukemia from immune attack.

B. Blazar, J. Barrett, 2009, The New England journal of medicine.

Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument

Opal L. Reddy, D. Stroncek, C. Mackall, 2019, Clinical hematology international.

Autoreactive, Cytotoxic T Lymphocytes Specific for Peptides Derived from Normal B-Cell Differentiation Antigens in Healthy Individuals and Patients with B-Cell Malignancies

G. Marti, W. Wilson, K. Rezvani, 2004, Clinical Cancer Research.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Ivan Martin, John Barrett, Donald G Phinney, 2016, Cytotherapy.

Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.

R. Childs, C. Dunbar, E. Sloand, 2002, Experimental hematology.

Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review

B. Dumitriu, D. Hammoud, J. Barrett, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens.

N. Young, M. Wlodarski, J. Maciejewski, 2002, Blood.

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

N. Geller, N. Young, P. Scheinberg, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.

N. Young, J. Maciejewski, A. Chaudhuri, 2000, Blood.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.

C. Dunbar, D. Couriel, J. Barrett, 1996, Blood.

Why is a 3-year NRM following allogeneic transplantation still stuck at approximately 20%?

J. Barrett, 2018, Best practice & research. Clinical haematology.

Rapid donor T‐cell engraftment increases the risk of chronic graft‐versus‐host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes

N. Geller, N. Young, D. Stroncek, 2013, American journal of hematology.

Separating GVHD and GVL Reactions

D. Mavroudis, J. Barrett, 2000 .

The transition from bench to bedside: lessons learned in the creation of a new T-cell product for the clinic.

J Barrett, S Solomon, J. Barrett, 2004, Cytotherapy.

Allogeneic marrow transplantation--dinosaur or bird?

J. Barrett, 2002, Cytotherapy.

Can we prevent or treat graft-versus-host disease with cellular-therapy?

R. Gale, O. Ringdén, H. Lazarus, 2020, Blood reviews.

Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell-Depleted Human Leukocyte Antigen-Matched Sibling Transplantation.

J. Barrett, M. Battiwalla, N. Dunavin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

S. Gore, J. Goldman, H. Prentice, 1990, Transplantation.

Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

N. Geller, H. Hedlin, R. Srinivasan, 2007 .

Human G‐CSF‐mobilized CD34‐positive peripheral blood progenitor cells can stimulate allogeneic T‐cell responses: implications for graft rejection in mismatched transplantation

N. Hensel, A. Raptis, R. Childs, 1999, British journal of haematology.

Neutrophil granule proteins as targets of leukemia-specific immune responses

K. Rezvani, J. Barrett, 2006, Current opinion in hematology.

Are UC blood transplants prone to developing leukemia?

J. Barrett, 2007, Cytotherapy.

Concise review Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

J. Barrett, F. Rhee, F. V. Rhee, 2002 .

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation.

J. Barrett, F. van Rhee, F. Van Rhee, 2002, Cytotherapy.

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

N. Hensel, F. van Rhee, J. Barrett, 2001, Blood.

HLA-tetramers to clinical scale from a single blood draw using dendritic cells and Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes

N. Hensel, J. Barrett, A. Madrigal, 2013 .

Impact of early CMV reactivation in cord blood stem cell recipients in the current era

M. Boeckh, J. Wingard, H. Lazarus, 2016, Bone Marrow Transplantation.

Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation – How much is acceptable?

F. Fakhrejahani, J. Barrett, M. Battiwalla, 2014, Hematology.

Impact of Early Cytomegalovirus Reactivation in Cord Blood Stem Cell Recipients in the Current Era

Riches, M. Boeckh, H. Lazarus, 2016 .

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

N. Geller, R. Srinivasan, R. Childs, 2004 .

Leukemia-Reactive T Cells in Adoptive Immunotherapy for Relapsed Leukemia After Allogeneic Transplantation

J. Barrett, Yin-Zhen Jiang, 2000 .

Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.

John Barrett, Neal Young, Peter Greenberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

M. Bishop, Li Yang, L. Wehrlen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors

J. Barrett, M. Battiwalla, B. Savani, 2016, Bone Marrow Transplantation.

In this issue of Blood , in a series of elegant studies in a transplantable mouse model of acute myeloid leukemia

J. Barrett, 2013 .

National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation.

D. Stroncek, J. Barrett, L. Harvath, 2002, Cytotherapy.

T-cell therapy for viral infections following transplantation: why stop at three viruses?

J. Barrett, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Myelodysplasia with Trisomy 8 Is Associated with a Cytotoxic CD8 T Cell Immune Response to Wilms Tumor-1 Protein (WT1).

D. Douek, K. Rezvani, N. Young, 2004 .

Granulocyte Colony Stimulating Factor Preferentially Causes Proliferation of Pre-Existing Monosomy 7 Cells in Aplastic Anemia and Myelodysplastic Syndrome Because of Abnormal Truncated GCSF-Receptors on These Cells.

N. Young, L. Mainwaring, S. Ramkissoon, 2004 .